L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea · Delayed Price · Currency is KRW

69,700

+5,800 (9.08%)

Apr 10, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Medical Products			65.93B	52.57B	45.68B	32.97B	29.15B
Medical Products Growth			25.40%	15.10%	38.53%	13.11%	37.24%
Total			65.93B	52.57B	45.68B	32.97B	29.15B
Total Growth			25.40%	15.10%	38.53%	13.11%	37.24%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
South Korea			61.99B	48.67B	43.45B	-	-
South Korea Growth			27.36%	12.01%	-	-	-
Export			3.94B	3.90B	2.22B	-	-
Export Growth			0.93%	75.28%	-	-	-
Total			65.93B	52.57B	45.68B	-	-
Total Growth			25.40%	15.10%	-	-	-

Source: S&P Global Market Intelligence.